Press Releases

Exact Sciences also to acquire biomarker and technology patents NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, April 27, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced that it has signed a five-year agreement with Exact...

Read More...

NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, April 10, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced BJU International published a study demonstrating that its SelectMDx(TM) for Prostate Cancer test can reduce overdiagnosis...

Read More...

NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CET, April 4, 2017 - MDxHealth SA (Euronext: MDXH.BR), today announced that it has signed an exclusive licensing deal with Ghent University in Belgium for its proprietary molecular diagnostic...

Read More...

NEWS RELEASE / REGULATED INFORMATION /  INSIDE INFORMATIONABSTRACT #490, POSTER SESSION 36                                                        ...

Read More...

NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - March 21, 2017 - MDxHealth SA (Euronext: MDXH.BR), today announced that it has signed a distribution agreement to make its SelectMDx(TM) for Prostate Cancer test available to Lab21 Clinical Laboratory...

Read More...

NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - March 8, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced that SelectMDx(TM) for Prostate Cancer, a non-invasive urine-based test that guides patient selection for prostate biopsy, will be used...

Read More...

NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - February 01, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced that it has been awarded a US Government Federal Supply Schedule Contract for medical laboratory testing services for ConfirmMDx®...

Read More...

NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - February 23, 2017 - MDxHealth SA (Euronext: MDXH.BR), today announced that it has signed a distribution agreement to make its SelectMDx(TM) for Prostate Cancer test available to Istituto...

Read More...

NEWS RELEASE   REGULATED INFORMATION  INSIDE INFORMATION  Record revenue of $30 million, up 70% from 2015Total test volume up 57% over 2015 Conference call for analysts and investors today at 15:00 CET / 09:00 EST, details below IRVINE, CA, and HERSTAL, BELGIUM - 7:00 AM,...

Read More...

Conference call for analysts and investors to be held on 23 February 2017 at 15:00 CET IRVINE, CA, and HERSTAL, BELGIUM - February 9, 2017 - MDxHealth SA (Euronext: MDXH.BR) or the "Company" today announced that it will release its full year results for the financial year ended 31 December 2016 on...

Read More...

Pages